Find your next paid study

Harmony Biosciences Management, Inc.NCT05536011

~$10 – $1,050

Phase 1

A Phase 1, First-in-human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VX-433 and Its Effects on the Pharmacokinetics of Midazolam and Bupropion

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of VX-433 following single and multiple ascending doses, as well a…

Narcolepsy Type 1 (NT1)

Vertex Pharmaceuticals IncorporatedNCT07584434

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of excessive dayt…

Narcolepsy

Eisai Inc.NCT07493265

Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia

A Phase 2a, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ORX750 in Subjects With Narcolepsy and Idiopathic Hypersomnia (CRYSTAL-1)

Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnia (IH) are rare conditions that make people feel very sleepy during the day (often r…

Centessa Pharmaceuticals (UK) LimitedNCT06752668

SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring

The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-country, observational study to evaluate the safety of solriamfetol exposure during pregna…

NarcolepsyObstructive Sleep ApneaPregnant Women and Their Offspring

Axsome Therapeutics, Inc.NCT06413420

~$10 – $1,050

Narcolepsy Type 1Narcolepsy Type 2Idiopathic Hypersomnia

A Phase 2, Long-term Extension Study of the Safety and Efficacy of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia Who Completed a Sponsored ORX750 Clinical Trial

This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 i…

Centessa Pharmaceuticals (UK) LimitedNCT07096674

Safety, Convenience, and Tolerability of a Nightly Single Oral Dose of Extended-release Sodium Oxybate in Children

The main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non…

Narcolepsy Type 1 (NT 1)

Stanford UniversityNCT06809803

~$10 – $6,250

Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, …

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more

A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-8…

Unhide® Project Also Known as The Unhide® Solve Together Unified Platform

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle i…

~$10 – $1,125

Children, Adolescents and Their Providers: the Narcolepsy Assessment Partnership (CATNAPTM)

CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on diseas…

Narcolepsy